Kyrgyz Republic vs Namibia: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Kyrgyz Republic
84.0%
in 2025
Namibia
83.0%
in 2025
Kyrgyz Republic rank
100th
Namibia rank
102nd
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Kyrgyz Republic
- Namibia
How they compare
Kyrgyz Republic currently reports 84.0% against 83.0% in Namibia, a difference of 1.0%.
The two have swapped places 1 time across 18 shared years of data; in 2008 it was Namibia ahead.
Kyrgyz Republic ranks 100th and Namibia ranks 102nd of 192 countries.
Across the 3 decades both report, Kyrgyz Republic averaged higher in 1 and Namibia in 1.
Head to head by decade
| Decade | Kyrgyz Republic | Namibia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 27.6% | 35.0% | 7.4% | Namibia |
| 2020s | 88.8% | 80.7% | 8.2% | Kyrgyz Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Kyrgyz Republic or Namibia?
- Kyrgyz Republic, at 84.0% against 83.0% in Namibia as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Kyrgyz Republic and Namibia?
- 1.0%, with Kyrgyz Republic ahead.
- How many years of comparable data are there for Kyrgyz Republic and Namibia?
- 18 years are reported by both, from 2008 to 2025.
- How do Kyrgyz Republic and Namibia rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Kyrgyz Republic ranks 100th and Namibia ranks 102nd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.